Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thoracic neuroendocrine tumors].

Elisabeth Brambilla1, Sylvie Lantuejoul

  • 1Département d'Anatomie et Cytologie Pathologiques, CHU Grenoble, France. EBrambilla@chu-grenoble.fr

Annales De Pathologie
|June 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IASLC Update on Classification of Pulmonary Neuroendocrine Neoplasms.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Primary cutaneous non neuroendocrine small cell carcinoma POU2F3 subtype: morphologic, immunohistochemical, transcriptomic and methylation analysis of two cases.

Virchows Archiv : an international journal of pathology·2026
Same author

A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committee.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Pharmacogenomic Characterization of a Large Cohort of Patient-Derived Cell Lines Identifies Therapeutic Strategies for Pleural Mesothelioma.

Cancer research·2025
Same author

MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial.

Translational oncology·2025

Neuroendocrine tumors of the lung and thymus have distinct types and grades. Differentiating these neuroendocrine tumors using specific criteria is crucial for patient prognosis.

Area of Science:

  • Oncology
  • Pathology
  • Endocrinology

Context:

  • Neuroendocrine tumors (NETs) represent a unique group of neoplasms originating in pulmonary and thymic tissues.
  • These tumors share common morphologic and biological neuroendocrine characteristics.
  • Accurate classification is essential due to significant clinical and prognostic implications.

Purpose:

  • To outline the classification system for pulmonary and thymic neuroendocrine tumors.
  • To delineate the histopathological types and malignancy grades within this tumor category.
  • To emphasize the importance of objective criteria for tumor distinction.

Summary:

  • Pulmonary and thymic neuroendocrine tumors are categorized into four histopathological types.
  • They are further classified into three malignancy grades: low (typical carcinoids), intermediate (atypical carcinoids), and high (large cell neuroendocrine carcinoma and small cell carcinoma).

Related Experiment Videos

  • Distinguishing between these types and grades relies on objective morphologic and phenotypic features.

    • Impact:

    • Provides a framework for consistent diagnosis of pulmonary and thymic neuroendocrine tumors.
    • Facilitates better patient stratification based on malignancy grade.
    • Enhances understanding of the clinical significance and prognostic value of specific neuroendocrine tumor features.